Research use only

Sold out · depth page

Semaglutide — recent literature 2024–2026 (RUO)

GLP-1 receptor agonist analogue

Semaglutide 5 mg · literature note

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. This research material is not a licensed semaglutide product.

Outcomes papers are literature context. Analytical papers describe how identity and quantitation are discussed in methods literature. The vial still needs a lot-matched supplier COA.

Two kinds of recent papers

Lincoff et al. (2023) and Colhoun et al. (2024) are outcomes-research context. The locked discovery cite on the parent brief remains Lau et al., PMID 26308095.

Kavibharathi et al., Tudan et al., and Kim et al. (2026) are analytical method papers. They support how HPLC and mass spectrometry are discussed for this analogue. They do not replace the lot COA.

Identity

Form

Lyophilized powder, sealed vial

Strength

5 mg lyophilized vial

Purity

≥99% HPLC (see the lot COA when a lot returns)

CAS

  • Semaglutide: 910463-68-2

PubMed

Selected literature

  • PMID 26308095 (2015) Lau et al., Journal of Medicinal Chemistry — semaglutide discovery

Recent literature (2023–2026)

  • PMID 37952131 (2023) Lincoff et al., NEJM — SELECT cardiovascular outcomes study (research context)
  • PMID 38796653 (2024) Colhoun et al., Nature Medicine — SELECT kidney outcomes analysis
  • PMID 42664897 (2026) Kavibharathi et al., Journal of Chromatography B — analytical methods review for semaglutide
  • PMID 42544568 (2026) Tudan et al., Bioanalysis — HPLC-MS/MS method for semaglutide in human plasma (method paper)
  • PMID 42514852 (2026) Kim et al., Pharmaceutics — LC-MS/MS quantification method for semaglutide

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Bench reconstitution

Follow the parent brief when a 5 mg lot is on the bench. This page does not change the reconstitution line.

Diluent page: bacteriostatic water.

Storage

Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.

Certificate of analysis

Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.

Lab FAQ

Does a 2026 method paper certify the catalog vial?

No. Method papers are not a lot COA. Use Notify when available and write request@pharmapeptidesrx.com. This page does not publish prices or banking details. Invoices go out from request@ only.

In this library

Sold out

Notify on restock

This lot is sold out. Write request@pharmapeptidesrx.com and we email you when it is back.